Yi Xiang

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients

Zhe Yang, Nong Yang, Qiuxiang Ou et al. · Clinical Cancer Research · 2018 · 544 citations

Medicine, Oncology, Pharmacology +17

The current status of biodegradable stent to treat benign luminal disease

Yueqi Zhu, Kai Yang, Ruoyu Cheng et al. · Materials Today · 2017 · 98 citations · Full text

Medicine, Bioengineering, Surgery +12

A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds

Liucheng Zhang, Yi Xiang, Hongbo Zhang et al. · Advanced Science · 2020 · 95 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Wei-Xiang Qi, Yi Xiang, Shengguang Zhao et al. · Cancer Immunology Immunotherapy · 2021 · 93 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance

Teizo Yoshimura, Mairi H McLean, Amiran Dzutsev et al. · The Journal of Immunology · 2018 · 90 citations · Full text

Life Sciences, Immunology, Microbiology +15